
Birmingham spinout Revitope Oncology Inc announces $10m investment
December 16, 2020: University of Birmingham spinout Revitope Oncology Inc has announced a $10m investment from leading Chinese biopharmaceutical company Junshi Biosciences.
Opportunities from the partner universities and the wider MICRA ecosystem
December 16, 2020: University of Birmingham spinout Revitope Oncology Inc has announced a $10m investment from leading Chinese biopharmaceutical company Junshi Biosciences.
Experts at Loughborough University have teamed up with the UK’s leading health and wellbeing store, Holland and Barrett, to create a unique personalised health and fitness app.
NanoSyrinx announces the appointment of Dr Jane Dancer to its Board as Non-Executive Director.
OVO Biomanufacturing has announced the completion of a new funding round to develop its novel technology platform to improve the manufacturing efficiency for viral vaccines and gene therapies.
NanoSyrinx, an emerging biotechnology company developing new therapeutic modalities for Cell & Gene editing, announced the closing of a Pre-Seed financing led by M Ventures, the corporate venture capital arm of Merck. BioCity (Nottingham, United Kingdom) and UK Innovation & Science Seed Fund also participated in the financing.
Tags Date Posted Posted By Midlands Innovation Commercialisation of Research Accelerator (MICRA) partner institution the University of Nottingham, have welcomed the news that one of
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.